HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland
- PMID: 22371006
- DOI: 10.1007/s00038-012-0352-2
HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland
Abstract
Objective: The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during a state-coordinated HPV vaccination program in Geneva, Switzerland, from September 2008 to June 2011.
Methods: State Medical Office coordinated the HPV vaccination program. Each service provider transmitted the list of the persons who had received their first, second, or third shot.
Results: The global coverage rates, 3 years after the program had been launched, were 63.72% for one dose, 63.22% for two doses, and 61.40% for three doses of the HPV vaccine.
Conclusion: This study shows that it is possible to obtain a good coverage rates after 3 years of a state-coordinated HPV vaccination program.
Similar articles
-
Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.Public Health Rep. 2015 May-Jun;130(3):202-6. doi: 10.1177/003335491513000306. Public Health Rep. 2015. PMID: 25931623 Free PMC article.
-
Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123. doi: 10.1080/21645515.2017.1385688. Epub 2017 Dec 13. Hum Vaccin Immunother. 2018. PMID: 29049007 Free PMC article.
-
Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates.Int J Public Health. 2010 Feb;55(1):25-34. doi: 10.1007/s00038-009-0081-3. Epub 2009 Oct 1. Int J Public Health. 2010. PMID: 19795095
-
Adolescent and young adult HPV vaccination in Australia: achievements and challenges.Prev Med. 2011 Oct;53 Suppl 1:S29-35. doi: 10.1016/j.ypmed.2011.08.015. Prev Med. 2011. PMID: 21962468 Review.
-
Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention.Expert Rev Vaccines. 2018 Dec;17(12):1093-1104. doi: 10.1080/14760584.2018.1547196. Epub 2018 Nov 29. Expert Rev Vaccines. 2018. PMID: 30417704 Review.
Cited by
-
Human Papillomavirus Infection and Vaccination: Knowledge, Attitude and Perception among Undergraduate Men and Women Healthcare University Students in Switzerland.Vaccines (Basel). 2019 Sep 26;7(4):130. doi: 10.3390/vaccines7040130. Vaccines (Basel). 2019. PMID: 31561629 Free PMC article.
-
Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.Public Health Rep. 2015 May-Jun;130(3):202-6. doi: 10.1177/003335491513000306. Public Health Rep. 2015. PMID: 25931623 Free PMC article.
-
Immunization Status of Young People Attending a Youth Clinic in Geneva, Switzerland.J Immigr Minor Health. 2016 Apr;18(2):353-9. doi: 10.1007/s10903-015-0185-1. J Immigr Minor Health. 2016. PMID: 25774037
-
Are we speaking the same language? an argument for the consistent use of terminology and definitions for childhood vaccination indicators.Hum Vaccin Immunother. 2019;15(3):740-747. doi: 10.1080/21645515.2018.1546526. Epub 2018 Dec 20. Hum Vaccin Immunother. 2019. PMID: 30457475 Free PMC article.
-
Factors Influencing the Decision to Vaccinate against HPV amongst a Population of Female Health Students.Vaccines (Basel). 2022 Apr 25;10(5):680. doi: 10.3390/vaccines10050680. Vaccines (Basel). 2022. PMID: 35632436 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
